Industry Research Reports

Home > Reports > Medical Care > Diabetes Devices and Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Diabetes Devices and Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-12

Pages: 169 Pages

Report ld: 2625220

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Diabetes Devices and Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Diabetes Devices and Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Diabetes Devices and Drugs by region & country, by Type, and by Application.

The Diabetes Devices and Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Devices and Drugs.

Market Segmentation

Report Metric
Details
Report Title
Diabetes Devices and Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Diabetes Devices and Drugs Companies Covered
Medtronic, BD, Johnson & Johnson, Abbott Laboratories, Novo Nordisk, Bristol-Myers Squibb, DexCom, Companion Medical, GlaxoSmithKline, Glenmark Pharmaceuticals, Novartis, Roche, Sanofi, MSD, Astrazeneca, Takeda, North China Pharmaceutical Group Corporation, Huadong Medicine, Dongbao Pharmaceutical, Hisun Pharmacy, KELUN, Ginwa, Tianan Pharmaceutical
Global Diabetes Devices and Drugs Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diabetes Devices and Drugs Market, Segment by Type
Diabetes Devices

Diabetes Drugs
Global Diabetes Devices and Drugs Market, Segment by Application
Diagnostic/Clinics

ICUs

Home Healthcare
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Diabetes Devices and Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Diabetes Devices and Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Diabetes Devices and Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Diabetes Devices and Drugs Product Introduction
    1.2 Global Diabetes Devices and Drugs Market Size Forecast
    1.3 Diabetes Devices and Drugs Market Trends & Drivers
        1.3.1 Diabetes Devices and Drugs Industry Trends
        1.3.2 Diabetes Devices and Drugs Market Drivers & Opportunity
        1.3.3 Diabetes Devices and Drugs Market Challenges
        1.3.4 Diabetes Devices and Drugs Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Diabetes Devices and Drugs Players Revenue Ranking (2023)
    2.2 Global Diabetes Devices and Drugs Revenue by Company (2019-2024)
    2.3 Key Companies Diabetes Devices and Drugs Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Diabetes Devices and Drugs Product Offered
    2.5 Key Companies Time to Begin Mass Production of Diabetes Devices and Drugs
    2.6 Diabetes Devices and Drugs Market Competitive Analysis
        2.6.1 Diabetes Devices and Drugs Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Diabetes Devices and Drugs Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Devices and Drugs as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Diabetes Devices
        3.1.2 Diabetes Drugs
    3.2 Global Diabetes Devices and Drugs Sales Value by Type
        3.2.1 Global Diabetes Devices and Drugs Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Diabetes Devices and Drugs Sales Value, by Type (2019-2030)
        3.2.3 Global Diabetes Devices and Drugs Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Diagnostic/Clinics
        4.1.2 ICUs
        4.1.3 Home Healthcare
    4.2 Global Diabetes Devices and Drugs Sales Value by Application
        4.2.1 Global Diabetes Devices and Drugs Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Diabetes Devices and Drugs Sales Value, by Application (2019-2030)
        4.2.3 Global Diabetes Devices and Drugs Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Diabetes Devices and Drugs Sales Value by Region
        5.1.1 Global Diabetes Devices and Drugs Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Diabetes Devices and Drugs Sales Value by Region (2019-2024)
        5.1.3 Global Diabetes Devices and Drugs Sales Value by Region (2025-2030)
        5.1.4 Global Diabetes Devices and Drugs Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Diabetes Devices and Drugs Sales Value, 2019-2030
        5.2.2 North America Diabetes Devices and Drugs Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Diabetes Devices and Drugs Sales Value, 2019-2030
        5.3.2 Europe Diabetes Devices and Drugs Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Diabetes Devices and Drugs Sales Value, 2019-2030
        5.4.2 Asia Pacific Diabetes Devices and Drugs Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Diabetes Devices and Drugs Sales Value, 2019-2030
        5.5.2 South America Diabetes Devices and Drugs Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Diabetes Devices and Drugs Sales Value, 2019-2030
        5.6.2 Middle East & Africa Diabetes Devices and Drugs Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Diabetes Devices and Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Diabetes Devices and Drugs Sales Value
    6.3 United States
        6.3.1 United States Diabetes Devices and Drugs Sales Value, 2019-2030
        6.3.2 United States Diabetes Devices and Drugs Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Diabetes Devices and Drugs Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Diabetes Devices and Drugs Sales Value, 2019-2030
        6.4.2 Europe Diabetes Devices and Drugs Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Diabetes Devices and Drugs Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Diabetes Devices and Drugs Sales Value, 2019-2030
        6.5.2 China Diabetes Devices and Drugs Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Diabetes Devices and Drugs Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Diabetes Devices and Drugs Sales Value, 2019-2030
        6.6.2 Japan Diabetes Devices and Drugs Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Diabetes Devices and Drugs Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Diabetes Devices and Drugs Sales Value, 2019-2030
        6.7.2 South Korea Diabetes Devices and Drugs Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Diabetes Devices and Drugs Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Diabetes Devices and Drugs Sales Value, 2019-2030
        6.8.2 Southeast Asia Diabetes Devices and Drugs Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Diabetes Devices and Drugs Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Diabetes Devices and Drugs Sales Value, 2019-2030
        6.9.2 India Diabetes Devices and Drugs Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Diabetes Devices and Drugs Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Medtronic
        7.1.1 Medtronic Profile
        7.1.2 Medtronic Main Business
        7.1.3 Medtronic Diabetes Devices and Drugs Products, Services and Solutions
        7.1.4 Medtronic Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.1.5 Medtronic Recent Developments
    7.2 BD
        7.2.1 BD Profile
        7.2.2 BD Main Business
        7.2.3 BD Diabetes Devices and Drugs Products, Services and Solutions
        7.2.4 BD Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.2.5 BD Recent Developments
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Profile
        7.3.2 Johnson & Johnson Main Business
        7.3.3 Johnson & Johnson Diabetes Devices and Drugs Products, Services and Solutions
        7.3.4 Johnson & Johnson Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.3.5 Abbott Laboratories Recent Developments
    7.4 Abbott Laboratories
        7.4.1 Abbott Laboratories Profile
        7.4.2 Abbott Laboratories Main Business
        7.4.3 Abbott Laboratories Diabetes Devices and Drugs Products, Services and Solutions
        7.4.4 Abbott Laboratories Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.4.5 Abbott Laboratories Recent Developments
    7.5 Novo Nordisk
        7.5.1 Novo Nordisk Profile
        7.5.2 Novo Nordisk Main Business
        7.5.3 Novo Nordisk Diabetes Devices and Drugs Products, Services and Solutions
        7.5.4 Novo Nordisk Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.5.5 Novo Nordisk Recent Developments
    7.6 Bristol-Myers Squibb
        7.6.1 Bristol-Myers Squibb Profile
        7.6.2 Bristol-Myers Squibb Main Business
        7.6.3 Bristol-Myers Squibb Diabetes Devices and Drugs Products, Services and Solutions
        7.6.4 Bristol-Myers Squibb Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.6.5 Bristol-Myers Squibb Recent Developments
    7.7 DexCom
        7.7.1 DexCom Profile
        7.7.2 DexCom Main Business
        7.7.3 DexCom Diabetes Devices and Drugs Products, Services and Solutions
        7.7.4 DexCom Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.7.5 DexCom Recent Developments
    7.8 Companion Medical
        7.8.1 Companion Medical Profile
        7.8.2 Companion Medical Main Business
        7.8.3 Companion Medical Diabetes Devices and Drugs Products, Services and Solutions
        7.8.4 Companion Medical Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.8.5 Companion Medical Recent Developments
    7.9 GlaxoSmithKline
        7.9.1 GlaxoSmithKline Profile
        7.9.2 GlaxoSmithKline Main Business
        7.9.3 GlaxoSmithKline Diabetes Devices and Drugs Products, Services and Solutions
        7.9.4 GlaxoSmithKline Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.9.5 GlaxoSmithKline Recent Developments
    7.10 Glenmark Pharmaceuticals
        7.10.1 Glenmark Pharmaceuticals Profile
        7.10.2 Glenmark Pharmaceuticals Main Business
        7.10.3 Glenmark Pharmaceuticals Diabetes Devices and Drugs Products, Services and Solutions
        7.10.4 Glenmark Pharmaceuticals Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.10.5 Glenmark Pharmaceuticals Recent Developments
    7.11 Novartis
        7.11.1 Novartis Profile
        7.11.2 Novartis Main Business
        7.11.3 Novartis Diabetes Devices and Drugs Products, Services and Solutions
        7.11.4 Novartis Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.11.5 Novartis Recent Developments
    7.12 Roche
        7.12.1 Roche Profile
        7.12.2 Roche Main Business
        7.12.3 Roche Diabetes Devices and Drugs Products, Services and Solutions
        7.12.4 Roche Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.12.5 Roche Recent Developments
    7.13 Sanofi
        7.13.1 Sanofi Profile
        7.13.2 Sanofi Main Business
        7.13.3 Sanofi Diabetes Devices and Drugs Products, Services and Solutions
        7.13.4 Sanofi Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.13.5 Sanofi Recent Developments
    7.14 MSD
        7.14.1 MSD Profile
        7.14.2 MSD Main Business
        7.14.3 MSD Diabetes Devices and Drugs Products, Services and Solutions
        7.14.4 MSD Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.14.5 MSD Recent Developments
    7.15 Astrazeneca
        7.15.1 Astrazeneca Profile
        7.15.2 Astrazeneca Main Business
        7.15.3 Astrazeneca Diabetes Devices and Drugs Products, Services and Solutions
        7.15.4 Astrazeneca Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.15.5 Astrazeneca Recent Developments
    7.16 Takeda
        7.16.1 Takeda Profile
        7.16.2 Takeda Main Business
        7.16.3 Takeda Diabetes Devices and Drugs Products, Services and Solutions
        7.16.4 Takeda Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.16.5 Takeda Recent Developments
    7.17 North China Pharmaceutical Group Corporation
        7.17.1 North China Pharmaceutical Group Corporation Profile
        7.17.2 North China Pharmaceutical Group Corporation Main Business
        7.17.3 North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Products, Services and Solutions
        7.17.4 North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.17.5 North China Pharmaceutical Group Corporation Recent Developments
    7.18 Huadong Medicine
        7.18.1 Huadong Medicine Profile
        7.18.2 Huadong Medicine Main Business
        7.18.3 Huadong Medicine Diabetes Devices and Drugs Products, Services and Solutions
        7.18.4 Huadong Medicine Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.18.5 Huadong Medicine Recent Developments
    7.19 Dongbao Pharmaceutical
        7.19.1 Dongbao Pharmaceutical Profile
        7.19.2 Dongbao Pharmaceutical Main Business
        7.19.3 Dongbao Pharmaceutical Diabetes Devices and Drugs Products, Services and Solutions
        7.19.4 Dongbao Pharmaceutical Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.19.5 Dongbao Pharmaceutical Recent Developments
    7.20 Hisun Pharmacy
        7.20.1 Hisun Pharmacy Profile
        7.20.2 Hisun Pharmacy Main Business
        7.20.3 Hisun Pharmacy Diabetes Devices and Drugs Products, Services and Solutions
        7.20.4 Hisun Pharmacy Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.20.5 Hisun Pharmacy Recent Developments
    7.21 KELUN
        7.21.1 KELUN Profile
        7.21.2 KELUN Main Business
        7.21.3 KELUN Diabetes Devices and Drugs Products, Services and Solutions
        7.21.4 KELUN Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.21.5 KELUN Recent Developments
    7.22 Ginwa
        7.22.1 Ginwa Profile
        7.22.2 Ginwa Main Business
        7.22.3 Ginwa Diabetes Devices and Drugs Products, Services and Solutions
        7.22.4 Ginwa Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.22.5 Ginwa Recent Developments
    7.23 Tianan Pharmaceutical
        7.23.1 Tianan Pharmaceutical Profile
        7.23.2 Tianan Pharmaceutical Main Business
        7.23.3 Tianan Pharmaceutical Diabetes Devices and Drugs Products, Services and Solutions
        7.23.4 Tianan Pharmaceutical Diabetes Devices and Drugs Revenue (US$ Million) & (2019-2024)
        7.23.5 Tianan Pharmaceutical Recent Developments

 8 Industry Chain Analysis
    8.1 Diabetes Devices and Drugs Industrial Chain
    8.2 Diabetes Devices and Drugs Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Diabetes Devices and Drugs Sales Model
        8.5.2 Sales Channel
        8.5.3 Diabetes Devices and Drugs Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Diabetes Devices and Drugs Market Trends
    Table 2. Diabetes Devices and Drugs Market Drivers & Opportunity
    Table 3. Diabetes Devices and Drugs Market Challenges
    Table 4. Diabetes Devices and Drugs Market Restraints
    Table 5. Global Diabetes Devices and Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Diabetes Devices and Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Diabetes Devices and Drugs Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Diabetes Devices and Drugs Product Type
    Table 9. Key Companies Time to Begin Mass Production of Diabetes Devices and Drugs
    Table 10. Global Diabetes Devices and Drugs Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Devices and Drugs as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Diabetes Devices and Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Diabetes Devices and Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Diabetes Devices and Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Diabetes Devices and Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Diabetes Devices and Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Diabetes Devices and Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Diabetes Devices and Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Diabetes Devices and Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Diabetes Devices and Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Diabetes Devices and Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Diabetes Devices and Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Diabetes Devices and Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Diabetes Devices and Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Diabetes Devices and Drugs Sales Value by Region (2019-2024) & (%)
    Table 27. Global Diabetes Devices and Drugs Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Diabetes Devices and Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Diabetes Devices and Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Diabetes Devices and Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 31. Medtronic Basic Information List
    Table 32. Medtronic Description and Business Overview
    Table 33. Medtronic Diabetes Devices and Drugs Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Medtronic (2019-2024)
    Table 35. Medtronic Recent Developments
    Table 36. BD Basic Information List
    Table 37. BD Description and Business Overview
    Table 38. BD Diabetes Devices and Drugs Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Diabetes Devices and Drugs Business of BD (2019-2024)
    Table 40. BD Recent Developments
    Table 41. Johnson & Johnson Basic Information List
    Table 42. Johnson & Johnson Description and Business Overview
    Table 43. Johnson & Johnson Diabetes Devices and Drugs Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Johnson & Johnson (2019-2024)
    Table 45. Johnson & Johnson Recent Developments
    Table 46. Abbott Laboratories Basic Information List
    Table 47. Abbott Laboratories Description and Business Overview
    Table 48. Abbott Laboratories Diabetes Devices and Drugs Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Abbott Laboratories (2019-2024)
    Table 50. Abbott Laboratories Recent Developments
    Table 51. Novo Nordisk Basic Information List
    Table 52. Novo Nordisk Description and Business Overview
    Table 53. Novo Nordisk Diabetes Devices and Drugs Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Novo Nordisk (2019-2024)
    Table 55. Novo Nordisk Recent Developments
    Table 56. Bristol-Myers Squibb Basic Information List
    Table 57. Bristol-Myers Squibb Description and Business Overview
    Table 58. Bristol-Myers Squibb Diabetes Devices and Drugs Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Bristol-Myers Squibb (2019-2024)
    Table 60. Bristol-Myers Squibb Recent Developments
    Table 61. DexCom Basic Information List
    Table 62. DexCom Description and Business Overview
    Table 63. DexCom Diabetes Devices and Drugs Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Diabetes Devices and Drugs Business of DexCom (2019-2024)
    Table 65. DexCom Recent Developments
    Table 66. Companion Medical Basic Information List
    Table 67. Companion Medical Description and Business Overview
    Table 68. Companion Medical Diabetes Devices and Drugs Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Companion Medical (2019-2024)
    Table 70. Companion Medical Recent Developments
    Table 71. GlaxoSmithKline Basic Information List
    Table 72. GlaxoSmithKline Description and Business Overview
    Table 73. GlaxoSmithKline Diabetes Devices and Drugs Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Diabetes Devices and Drugs Business of GlaxoSmithKline (2019-2024)
    Table 75. GlaxoSmithKline Recent Developments
    Table 76. Glenmark Pharmaceuticals Basic Information List
    Table 77. Glenmark Pharmaceuticals Description and Business Overview
    Table 78. Glenmark Pharmaceuticals Diabetes Devices and Drugs Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Glenmark Pharmaceuticals (2019-2024)
    Table 80. Glenmark Pharmaceuticals Recent Developments
    Table 81. Novartis Basic Information List
    Table 82. Novartis Description and Business Overview
    Table 83. Novartis Diabetes Devices and Drugs Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Novartis (2019-2024)
    Table 85. Novartis Recent Developments
    Table 86. Roche Basic Information List
    Table 87. Roche Description and Business Overview
    Table 88. Roche Diabetes Devices and Drugs Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Roche (2019-2024)
    Table 90. Roche Recent Developments
    Table 91. Sanofi Basic Information List
    Table 92. Sanofi Description and Business Overview
    Table 93. Sanofi Diabetes Devices and Drugs Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Sanofi (2019-2024)
    Table 95. Sanofi Recent Developments
    Table 96. MSD Basic Information List
    Table 97. MSD Description and Business Overview
    Table 98. MSD Diabetes Devices and Drugs Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Diabetes Devices and Drugs Business of MSD (2019-2024)
    Table 100. MSD Recent Developments
    Table 101. Astrazeneca Basic Information List
    Table 102. Astrazeneca Description and Business Overview
    Table 103. Astrazeneca Diabetes Devices and Drugs Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Astrazeneca (2019-2024)
    Table 105. Astrazeneca Recent Developments
    Table 106. Takeda Basic Information List
    Table 107. Takeda Description and Business Overview
    Table 108. Takeda Diabetes Devices and Drugs Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Takeda (2019-2024)
    Table 110. Takeda Recent Developments
    Table 111. North China Pharmaceutical Group Corporation Basic Information List
    Table 112. North China Pharmaceutical Group Corporation Description and Business Overview
    Table 113. North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Diabetes Devices and Drugs Business of North China Pharmaceutical Group Corporation (2019-2024)
    Table 115. North China Pharmaceutical Group Corporation Recent Developments
    Table 116. Huadong Medicine Basic Information List
    Table 117. Huadong Medicine Description and Business Overview
    Table 118. Huadong Medicine Diabetes Devices and Drugs Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Huadong Medicine (2019-2024)
    Table 120. Huadong Medicine Recent Developments
    Table 121. Dongbao Pharmaceutical Basic Information List
    Table 122. Dongbao Pharmaceutical Description and Business Overview
    Table 123. Dongbao Pharmaceutical Diabetes Devices and Drugs Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Dongbao Pharmaceutical (2019-2024)
    Table 125. Dongbao Pharmaceutical Recent Developments
    Table 126. Hisun Pharmacy Basic Information List
    Table 127. Hisun Pharmacy Description and Business Overview
    Table 128. Hisun Pharmacy Diabetes Devices and Drugs Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Hisun Pharmacy (2019-2024)
    Table 130. Hisun Pharmacy Recent Developments
    Table 131. KELUN Basic Information List
    Table 132. KELUN Description and Business Overview
    Table 133. KELUN Diabetes Devices and Drugs Products, Services and Solutions
    Table 134. Revenue (US$ Million) in Diabetes Devices and Drugs Business of KELUN (2019-2024)
    Table 135. KELUN Recent Developments
    Table 136. Ginwa Basic Information List
    Table 137. Ginwa Description and Business Overview
    Table 138. Ginwa Diabetes Devices and Drugs Products, Services and Solutions
    Table 139. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Ginwa (2019-2024)
    Table 140. Ginwa Recent Developments
    Table 141. Tianan Pharmaceutical Basic Information List
    Table 142. Tianan Pharmaceutical Description and Business Overview
    Table 143. Tianan Pharmaceutical Diabetes Devices and Drugs Products, Services and Solutions
    Table 144. Revenue (US$ Million) in Diabetes Devices and Drugs Business of Tianan Pharmaceutical (2019-2024)
    Table 145. Tianan Pharmaceutical Recent Developments
    Table 146. Key Raw Materials Lists
    Table 147. Raw Materials Key Suppliers Lists
    Table 148. Diabetes Devices and Drugs Downstream Customers
    Table 149. Diabetes Devices and Drugs Distributors List
    Table 150. Research Programs/Design for This Report
    Table 151. Key Data Information from Secondary Sources
    Table 152. Key Data Information from Primary Sources
    Table 153. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Diabetes Devices and Drugs Product Picture
    Figure 2. Global Diabetes Devices and Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Diabetes Devices and Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Diabetes Devices and Drugs Report Years Considered
    Figure 5. Global Diabetes Devices and Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Diabetes Devices and Drugs Revenue in 2023
    Figure 7. Diabetes Devices and Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Diabetes Devices Picture
    Figure 9. Diabetes Drugs Picture
    Figure 10. Global Diabetes Devices and Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Diabetes Devices and Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Diagnostic/Clinics
    Figure 13. Product Picture of ICUs
    Figure 14. Product Picture of Home Healthcare
    Figure 15. Global Diabetes Devices and Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Diabetes Devices and Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Diabetes Devices and Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Diabetes Devices and Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Diabetes Devices and Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Diabetes Devices and Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Diabetes Devices and Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Diabetes Devices and Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Diabetes Devices and Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Diabetes Devices and Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Diabetes Devices and Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Diabetes Devices and Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Diabetes Devices and Drugs Sales Value (%), (2019-2030)
    Figure 28. United States Diabetes Devices and Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Diabetes Devices and Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Diabetes Devices and Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Diabetes Devices and Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Diabetes Devices and Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Diabetes Devices and Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Diabetes Devices and Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Diabetes Devices and Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Diabetes Devices and Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Diabetes Devices and Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Diabetes Devices and Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Diabetes Devices and Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Diabetes Devices and Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Diabetes Devices and Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Diabetes Devices and Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Diabetes Devices and Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Diabetes Devices and Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Diabetes Devices and Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Diabetes Devices and Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Diabetes Devices and Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Diabetes Devices and Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 49. Diabetes Devices and Drugs Industrial Chain
    Figure 50. Diabetes Devices and Drugs Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation

Description

The global market for Diabetes Devices and Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Diabetes Devices and Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Diabetes Devices and Drugs by region & country, by Type, and by Application.

The Diabetes Devices and Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Devices and Drugs.

Market Segmentation